U.S. panel backs HPV vaccine for males (Reuters)

Reuters - Merck & Co's cervical cancer vaccine is safe and effective for preventing genital warts in males ages 9 to 26, a U.S. advisory panel said on Wednesday.

Read more | Previous | Next